Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Dysregulation of Transposable Elements and Piwi-Interacting RNAs in Myelodysplastic Neoplasms

Zdenek Krejcik, David Kundrat, Monika Belickova, Jiri Klema, Andrea Hrustincova, Iva Trsova, Jaroslav Cermak, Anna Jonasova, Michaela Dostalova Merkerova

Blood (2024) 144 (Supplement 1): 4571.

https://doi.org/10.1182/blood-2024-207109

Published: 2024

Journal Articles

Interferon-Related DNA Damage Resistance Signature Genes Predict Chemoresistance in Acute Myeloid Leukemia

Ela Cerovska, David Kundrat, Zdenek Krejcik, Cyril Salek, Jan Musil, Michaela Dostalova Merkerova, Monika Belickova, Hana Remesova

Blood (2024) 144 (Supplement 1): 4294.

https://doi.org/10.1182/blood-2024-203188

Published: 2024

Journal Articles

Accelerated Progression in Lower-Risk Myelodysplastic Neoplasms: Attenuated Cell Cycle, DNA Damage Response, and Augmented Oncogenic Transcriptome Signatures

Monika Kaisrlikova, Zuzana Lenertová, Pavla Koralkova, Iva Trsová, David Kundrat, Michaela Dostalova Merkerova, Hana Votavova, Zdenek Krejcik, Anna Jonasova, Jaroslav Cermak, Vladimir Divoky, Monika Belickova

Blood (2023) 142 (Supplement 1): 6454.

https://doi.org/10.1182/blood-2023-180496

Published: 2023

Journal Articles

Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms

Iva Trsová, Andrea Hrustincova, Monika Belickova, Monika Kaisrlikova, Zuzana Lenertová, David Kundrat, Zdenek Krejcik, Jitka Vesela, Jaroslav Cermak, Anna Jonasova, Michaela Dostalova Merkerova

Blood (2023) 142 (Supplement 1): 3218.

https://doi.org/10.1182/blood-2023-179068

Published: 2023

Journal Articles

Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes

Monika Kaisrlikova, Iva Trsová, Zuzana Lenertova, Jitka Vesela, David Kundrat, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Martin Vostry, Jaroslav Cermak, Monika Belickova

Blood (2022) 140 (Supplement 1): 4020–4021.

https://doi.org/10.1182/blood-2022-168503

Published: 2022

Journal Articles

Upregulation of ZEB1 -Derived Circular RNAs Is Associated with SF3B1 -Mutated Myelodysplastic Neoplasms

Iva Trsová, Monika Belickova, Andrea Hrustincova, Monika Kaisrlikova, Zuzana Lenertova, David Kundrat, Zdenek Krejcik, Jitka Vesela, Jiri Klema, Petr Ryšavý, Jaroslav Cermak, Michaela Dostalova Merkerova

Blood (2022) 140 (Supplement 1): 4005–4006.

https://doi.org/10.1182/blood-2022-159466

Published: 2022

Journal Articles

Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1 Mutations on Their Expression

Michaela Dostalova Merkerova, David Kundrat, Zdenek Krejcik, Andrea Hrustincova, Iva Trsova, Katarina Szikszai, Monika Kaisrlikova, Jitka Vesela, Jiri Klema, Jaroslav Cermak, Monika Belickova

Blood (2021) 138 (Supplement 1): 2590.

https://doi.org/10.1182/blood-2021-149633

Published: 2021

Journal Articles

Circulating Small Noncoding RNAs As Novel Semi-Invasive Markers of Patient Survival in Myelodysplastic Syndromes

Michaela Dostalova Merkerova, PhD MSc, Andrea Hrustincova, Zdenek Krejcik, David Kundrat, Katarina Szikszai, PhD, Jaroslav Cermak, Jitka Vesela, Monika Hruba, Monika Belickova, PhD

Blood (2019) 134 (Supplement_1): 3004.

https://doi.org/10.1182/blood-2019-126520

Published: 2019

Journal Articles

RUNX1 Mutation Accompanied with Dysregulated Cellular Senescence in Lower-Risk Myelodysplastic Syndrome Patients Is Associated with Disease Progression

Monika Hruba, Jitka Vesela, Hana Votavova, PhD, Michaela Dostalova Merkerova, PhD MSc, David Kundrat, Katarina Szikszai, PhD, Marie Lauermanova, MD, Zuzana Zemanova, PhD, Anna Jonasova, MD PhD, Jaroslav Cermak, MD PhD, Monika Belickova, PhD

Blood (2019) 134 (Supplement_1): 4230.

https://doi.org/10.1182/blood-2019-131150

Published: 2019

Journal Articles

Relationship between Altered Gene Expression and DNA Methylation of the DLK1-DIO3 region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Michaela Dostalova Merkerova, PhD MSc, Hana Remesova, Zdenek Krejcik, Nikoleta Loudova, Andrea Hrustincova, Katarina Szikszai, PhD, Jitka Vesela, MSc, Jaroslav Cermak, MD PhD, Anna Jonasova, MD, Monika Belickova, PhD

Blood (2018) 132 (Supplement 1): 5496.

https://doi.org/10.1182/blood-2018-99-113378

Published: 2018

Journal Articles

Deregulated Expression of Long Noncoding RNAs H19 , LEF1-AS1 , TCL6, and WT1-AS1 Predicts Poor Outcome of Patients with Myelodysplastic Syndromes

Michaela Dostalova Merkerova, PhD MSc, Nikoleta Loudova, Katarina Szikszai, PhD, Zdenek Krejcik, Jiri Klema, Pavla Pecherkova, Andrea Hrustincova, Jitka Vesela, MSc, Jaroslav Cermak, MD PhD, Anna Jonasova, MD, Monika Belickova, PhD

Blood (2018) 132 (Supplement 1): 5498.

https://doi.org/10.1182/blood-2018-99-116071

Published: 2018

Journal Articles

Mutations in RUNX1 and TP53 Genes Predict Progression in Patients with Lower-Risk Myelodysplastic Syndrome

Monika Hruba, MSc, Jitka Vesela, MSc, Hana Votavova, PhD, Michaela Dostalova Merkerova, PhD MSc, Katarina Szikszai, PhD, Marie Lauermannova, MD, Zuzana Zemanova, PhD, Anna Jonasova, MD, Jaroslav Cermak, MD PhD, Monika Belickova, PhD

Blood (2018) 132 (Supplement 1): 5519.

https://doi.org/10.1182/blood-2018-99-118048

Published: 2018

Journal Articles

Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis

Zuzana Zemanova, Kyra Michalova, PhD, Halka Buryova, Jana Brezinova, PhD, Libuse Lizcova, Karla Kostylkova, Iveta Sarova, PhD, Silvia Izakova, Sarka Ransdorfova, Zdenek Krejcik, Michaela Dostalova Merkerova, PhD, Magda Siskova, MD, Anna T Jonasova, MD, Radana Neuwirtova, MD, PhD, Jaroslav Cermak, PhD

Blood (2013) 122 (21): 1559.

https://doi.org/10.1182/blood.V122.21.1559.1559

Published: 2013

Journal Articles

Changes in Gene Expression Profiles in Patients with 5q- Syndrome Caused by Lenalidomide Treatment

Monika Belickova, Jaroslav Cermak, Jitka Vesela, Eliska Cechova, Zuzana Zemanova, Kyra Michalova, PhD, Michaela Dostalova Merkerova, Anna Jonasova, MD

Blood (2011) 118 (21): 5023.

https://doi.org/10.1182/blood.V118.21.5023.5023

Published: 2011

Journal Articles

Gene Expression Changes In Patients with 5q- Syndrome Treated with Lenalidomide

Monika Belickova, Jaroslav Cermak, Kamila Fejglova, Michaela Dostalova Merkerova, Radana Neuwirtova, MD, PhD, Miroslav Caniga, Magda Siskova, Libor Cervinek, Anna Jonasova, MD

Blood (2010) 116 (21): 4641.

https://doi.org/10.1182/blood.V116.21.4641.4641

Published: 2010

NARROW

Dysregulation of Transposable Elements and Piwi-Interacting RNAs in Myelodysplastic Neoplasms

Interferon-Related DNA Damage Resistance Signature Genes Predict Chemoresistance in Acute Myeloid Leukemia

Accelerated Progression in Lower-Risk Myelodysplastic Neoplasms: Attenuated Cell Cycle, DNA Damage Response, and Augmented Oncogenic Transcriptome Signatures

Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms

Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes

Upregulation of ZEB1 -Derived Circular RNAs Is Associated with SF3B1 -Mutated Myelodysplastic Neoplasms

Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1 Mutations on Their Expression

Circulating Small Noncoding RNAs As Novel Semi-Invasive Markers of Patient Survival in Myelodysplastic Syndromes

RUNX1 Mutation Accompanied with Dysregulated Cellular Senescence in Lower-Risk Myelodysplastic Syndrome Patients Is Associated with Disease Progression

Relationship between Altered Gene Expression and DNA Methylation of the DLK1-DIO3 region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Deregulated Expression of Long Noncoding RNAs H19 , LEF1-AS1 , TCL6, and WT1-AS1 Predicts Poor Outcome of Patients with Myelodysplastic Syndromes

Mutations in RUNX1 and TP53 Genes Predict Progression in Patients with Lower-Risk Myelodysplastic Syndrome

Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis

Changes in Gene Expression Profiles in Patients with 5q- Syndrome Caused by Lenalidomide Treatment

Gene Expression Changes In Patients with 5q- Syndrome Treated with Lenalidomide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only